A Phase II Study of Oral Panobinostat (LBH589) and Rituximab to Treat Diffuse Large B Cell Lymphoma (DLBCL)
Jewish General Hospital
Jewish General Hospital
Mayo Clinic
Mayo Clinic
Fondazione Italiana Linfomi - ETS
Massachusetts General Hospital
M.D. Anderson Cancer Center
Duke University
City of Hope Medical Center